Erin Mangan

1.1k citations

39 papers · 867 indexed · h-index 15

Co-authors: James W. Gober Hubert van Hoogstraten Neil M.H. Graham Yong Lin James A. Wingrove Janet van Adelsberg Gerd R Burmester Jeffrey C. Edberg
Topics: Rheumatoid Arthritis Research and Therapies (29 papers)Systemic Lupus Erythematosus Research (14 papers)Chronic Lymphocytic Leukemia Research (13 papers)
Cited by: Rheumatology Hematology Immunology
Journals: Journal of Clinical Investigation Genes & Development The Journal of Immunology
Partner nations: United States United Kingdom France

In The Last Decade

Erin Mangan

38 papers receiving 847 citations

Peers

Countries citing papers authored by Erin Mangan

Since Specialization

Citations

This map shows the geographic impact of Erin Mangan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Mangan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Mangan more than expected).

Fields of papers citing papers by Erin Mangan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Mangan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Mangan. The network helps show where Erin Mangan may publish in the future.

Co-authorship network of co-authors of Erin Mangan

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Mangan. A scholar is included among the top collaborators of Erin Mangan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Mangan. Erin Mangan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies 2020 ·Arthritis Research & Therapy ·Mark C. Genovese,Roy Fleischmann,Alan Kivitz,Eun Bong Lee,Hubert van Hoogstraten,Toshio Kimura,Gregory St John,Erin Mangan,Gerd R Burmester	26
2	Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs 2019 ·Rheumatology and Therapy ·Alvin F. Wells,Janie Parrino,Erin Mangan,Anne Paccaly,Yong Lin,Christine Xu,Chunpeng Fan,Neil M.H. Graham,Hubert van Hoogstraten,Albert Torri	25
3	Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs 2019 ·Advances in Therapy ·Ernest Choy,Nick Freemantle,Clare Proudfoot,Chieh-I Chen,(unknown),Andreas Kuznik,Hubert van Hoogstraten,Erin Mangan,Paulo Carita,(unknown)	6
4	Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale 2019 ·The Journal of Rheumatology ·Laure Gossec,Vibeke Strand,Clare Proudfoot,Chieh-I Chen,(unknown),Toshio Kimura,Hubert van Hoogstraten,Erin Mangan,Matthew Reaney	10
5	Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis 2018 ·Arthritis Research & Therapy ·Vibeke Strand,Laure Gossec,Clare Proudfoot,Chieh-I Chen,Matthew Reaney,(unknown),Toshio Kimura,Janet van Adelsberg,Yong Lin,Erin Mangan,Hubert van Hoogstraten,Gerd R Burmester	26
6	Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose? 2018 ·International Urogynecology Journal ·Howard B. Goldman,Matthias Oelke,Steven A. Kaplan,(unknown),David W. Russell,Martin Carlsson,Daniel Arumí,Erin Mangan,Fady Ntanios	6
7	THU0217 Similar efficacy and safety of sarilumab 150 mg or 200 mg q2w regardless of primary (1°) or secondary (2°) failure with tnf inhibitors 2018 ·Annals of the Rheumatic Diseases ·Roy Fleischmann,Alberto Spindler,Alan Kivitz,Daniel Ching,Erin Mangan,Tomoatsu Kimura,(unknown),Gerd R Burmester	1
8	222 Efficacy of sarilumab in patients with rheumatoid arthritis who previously received sarilumab or tocilizumab 2018 ·Lara D. Veeken ·Paul Emery,Hubert van Hoogstraten,Shyamalie Jayawardena,Erin Mangan,(unknown),Patrick Verschueren	4
9	THU0215 Efficacy of sarilumab in patients with rheumatoid arthritis with and without previous response to tocilizumab 2018 ·Annals of the Rheumatic Diseases ·Patrick Verschueren,Paul Emery,Hubert van Hoogstraten,(unknown),Erin Mangan,Alfons A den Broeder	5
10	Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors 2017 ·RMD Open ·Vibeke Strand,Matthew Reaney,Chieh-I Chen,Clare Proudfoot,(unknown),Déborah Bauer,Erin Mangan,Neil M.H. Graham,Hubert van Hoogstraten,Yong Lin,César Pacheco‐Tena,Roy Fleischmann	31
11	Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial 2016 ·Annals of the Rheumatic Diseases ·Gerd R Burmester,Yong Lin,Rahul Patel,Janet van Adelsberg,Erin Mangan,Neil M.H. Graham,Hubert van Hoogstraten,Déborah Bauer,Juan Ignacio Vargas,Eun Bong Lee	227
12	SAT0160 Clinical and Radiographic Outcomes after 2 Years of Sarilumab in Patients with Rheumatoid Arthritis 2016 ·Annals of the Rheumatic Diseases ·Désirée van der Heijde,Janet van Adelsberg,(unknown),Hubert van Hoogstraten,Erin Mangan,Neil M.H. Graham,Chunpeng Fan,Alberto Spindler,Mark C. Genovese	5
13	AB0251 Early Onset of Benefit by Patient-Reported Outcomes (PROs) with Sarilumab Treatment in RA 2016 ·Annals of the Rheumatic Diseases ·Vibeke Strand,C. Chen,Pooja Mahajan,Mark Kosinski,Erin Mangan,Hubert van Hoogstraten,(unknown),Yong Lin,Edward Keystone,Jürgen Braun	1
14	Development of a predictive model for urgency urinary incontinence 2016 ·Contemporary Clinical Trials ·Amanda Darekar,Martin Carlsson,(unknown),Fady Ntanios,Erin Mangan,Daniel Arumí,David Scholfield	6
15	Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double‐blind, placebo‐controlled EIGHT trial 2014 ·British Journal of Urology ·Christopher R. Chapple,Tim Schneider,François Haab,Franklin Sun,(unknown),David Scholfield,(unknown),Erin Mangan	28
16	1962 AGE, GENDER AND NOCTURNAL URGENCY SEVERITY PREDICT RESPONSE TO ANTIMUSCARINIC TREATMENT 2013 ·The Journal of Urology ·Jeffrey P. Weiss,(unknown),Erin Mangan	1
17	The Unique Cytoplasmic Domain of Human FcγRIIIA Regulates Receptor-Mediated Function 2012 ·The Journal of Immunology ·Xiaoli Li,(unknown),Erin Mangan,Kaihong Su,Andrew Gibson,(unknown),Jeffrey C. Edberg,Robert P. Kimberly	20
18	C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific 2000 ·Journal of Clinical Investigation ·Mary‐Pat Stein,Jeffrey C. Edberg,Robert P. Kimberly,Erin Mangan,Dwaipayan Bharadwaj,Carolyn Mold,Terry W. Du Clos	180
19	FlbT Couples Flagellum Assembly to Gene Expression in Caulobacter crescentus 1999 ·Journal of Bacteriology ·Erin Mangan,Jaleh Malakooti,(unknown),Paul Anderson,Bert Ely,James W. Gober	47
20	Temporal and spatial regulation of fliP, an early flagellar gene of Caulobacter crescentus that is required for motility and normal cell division 1995 ·Journal of Bacteriology ·James W. Gober,(unknown),Michael Jarvis,Erin Mangan,(unknown),James A. Wingrove	24

About Erin Mangan

Erin Mangan is a scholar working on Rheumatology, Genetics and Hematology, having authored 39 papers that have together received 867 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (29 papers), Systemic Lupus Erythematosus Research (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). The work is most often cited by research in Rheumatology (397 citations), Hematology (216 citations) and Immunology (212 citations). Erin Mangan has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include James W. Gober, Hubert van Hoogstraten, Neil M.H. Graham, Yong Lin, James A. Wingrove, Janet van Adelsberg, Gerd R Burmester, Jeffrey C. Edberg, Robert P. Kimberly and Eun Bong Lee. Their work appears in journals such as Journal of Clinical Investigation, Genes & Development and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact